Imperative Care announced today that it expanded its Zoom Stroke System with the launch of its Zoom DuoPort technology. Zoom DuoPort allows physicians to continue using the novel continuous dual-aspiration technique (CDAT) on two Zoom aspiration catheters simultaneously from a single vacuum source. CDAT enables enhanced aspiration control and … [Read more...] about Imperative Care expands Zoom Stroke System with new dual-catheter launch
Technologies & Devices
FastWave Medical earns nod to begin IVL feasibility study
FastWave Medical announced today that it received Institutional Review Board (IRB) approval to begin a coronary feasibility study. The study utilizes Sola, the company's novel laser intravascular lithotripsy (IVL) system. FastWave partnered with Clinical Accelerator to secure the approval, which paves the way for its planned U.S. pivotal … [Read more...] about FastWave Medical earns nod to begin IVL feasibility study
Boston Scientific completes SoniVie acquisition
Boston Scientific announced today that it completed its previously announced acquisition of SoniVie. In March, Boston Scientific announced that it agreed to acquire the intravascular ultrasound system developer. This acquisition brings Boston Scientific into the now-competitive renal denervation (RDN) space. Recor Medical received a landmark … [Read more...] about Boston Scientific completes SoniVie acquisition
Route 92 Medical settles patent spat with Q’Apel
Route 92 Medical announced today that it settled the patent litigation filed against Q’Apel Medical over delivery catheter intellectual property. San Mateo, California–based Route 92 develops a suite of reperfusion and access systems leveraging the patented Tenzing delivery catheter. The products aim to improve the efficiency of endovascular … [Read more...] about Route 92 Medical settles patent spat with Q’Apel
Endospan has positive aortic arch stent graft study results
Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system. Results came out of the statistical dissection primary arm from the TRIOMPHE FDA investigational device exemption (IDE) study. Investigators presented findings at the American Association for Thoracic Surgery (AATS) … [Read more...] about Endospan has positive aortic arch stent graft study results
Orchestra BioMed wins FDA IDE for sirolimus-angioballoon
Orchestra BioMed (Nasdaq:OBIO) announced today that it received FDA investigational device exemption (IDE) for its Virtue drug-coated balloon. It marks the second major regulatory milestone for Orchestra BioMed in just a week. The company last week picked up FDA breakthrough device designation for its atrioventricular interval modulation (AVIM) … [Read more...] about Orchestra BioMed wins FDA IDE for sirolimus-angioballoon
Medtronic reports more positive outcomes with Affera PFA tech
Medtronic [WtwhTicker symbol="MDT"](NYSE: MDT)[/WtwhTicker] today announced positive clinical outcomes from two studies of its pulsed field ablation (PFA) technologies. The studies looked at the Affera family of technologies. Those include the next-generation Sphere-360 single-shot PFA catheter and the Sphere-9 combination mapping and … [Read more...] about Medtronic reports more positive outcomes with Affera PFA tech
New data supports Abbott Volt pulsed field ablation system
Abbott (NYSE:ABT) today announced new study data demonstrating the safety and efficacy of its Volt pulsed field ablation (PFA) system. The Volt CE Mark study evaluated Volt's safety and efficacy out to 12 months for treating AFib. Data highlighted the system's safety profile along with its ability to achieve results with fewer therapy … [Read more...] about New data supports Abbott Volt pulsed field ablation system
Medtronic wins FDA nod for world’s smallest defibrillation lead
Medtronic [WtwhTicker symbol="MDT"](NYSE: MDT)[/WtwhTicker] announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle placement. It built OmniaSecure on its reliable SelectSecure Model 3830 pacing lead for catheter delivery. It adds to the wide-ranging Medtronic portfolio of lead solutions for precise … [Read more...] about Medtronic wins FDA nod for world’s smallest defibrillation lead
Johnson & Johnson MedTech shares strong 3-month Omnypulse data
Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse platform. Omnypulse features the Omnypulse catheter and the Trupulse generator. The company offers the catheter as a large-tip, 12 mm device with Carto 3 system integration. It features contact force feedback and enhanced … [Read more...] about Johnson & Johnson MedTech shares strong 3-month Omnypulse data
